|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets: | ||||||||||
| Cash and cash equivalents | ||||||||||
| Prepaid expenses and other current assets | ||||||||||
| Total current assets | ||||||||||
| Property and equipment, net | ||||||||||
| Other assets | ||||||||||
| Total assets | ||||||||||
| Liabilities, redeemable convertible preferred stock and stockholders' equity | ||||||||||
| Current liabilities: | ||||||||||
| Accounts payable | ||||||||||
| Accrued expenses and other current liabilities | ||||||||||
| Total current liabilities | ||||||||||
| Deferred rent, net of current portion | ||||||||||
| Other long term liabilities | ||||||||||
| Total liabilities | ||||||||||
| Stockholders' equity: | ||||||||||
| Common stock, $0.001 par value: 280,000,000 shares authorized as of September 30, 2023 and December 31, 2022; 36,091,075 and 35,575,694 shares issued as of September 30, 2023 and December 31, 2022, respectively; 36,083,742 and 35,516,249 shares outstanding as of September 30, 2023 and December 31, 2022, respectively | ||||||||||
| Additional paid-in capital | ||||||||||
| Accumulated deficit | ||||||||||
| Total stockholders' equity | ||||||||||
| Total liabilities and stockholders' equity |
Loading...
